Vertex Pharmaceuticals Inc (VRTX)
397.27
+0.63
(+0.16%)
USD |
NASDAQ |
Dec 20, 16:00
395.00
-2.27
(-0.57%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash from Operations (TTM): -842.60M for Sept. 30, 2024
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Eli Lilly and Co | 6.032B |
| Gilead Sciences Inc | 10.02B |
| Bristol-Myers Squibb Co | 15.00B |
| Pfizer Inc | 11.26B |
| PTC Therapeutics Inc | -177.97M |